(Q33459052)

English

Treatment of persistent or recurrent ovarian carcinoma with sequential methotrexate and 5-fluorouracil

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

27 July 2017

Treatment of persistent or recurrent ovarian carcinoma with sequential methotrexate and 5-fluorouracil (English)

1 reference

stated in

Europe PubMed Central

27 July 2017

1 reference

1 reference

1 reference

Chambers JT

1

1 reference

stated in

Europe PubMed Central

PubMed ID

3957121

retrieved

27 July 2017

Schwartz PE

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

3957121

retrieved

27 July 2017

language of work or name

English

0 references

publication date

1 March 1986

1 reference

stated in

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

23

1 reference

stated in

Europe PubMed Central

27 July 2017

3

1 reference

stated in

Europe PubMed Central

27 July 2017

346-349

1 reference

stated in

Europe PubMed Central

PubMed ID

3957121

retrieved

27 July 2017

Identifiers

DOI

10.1016/0090-8258(86)90136-8

1 reference

stated in

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

PubMed ID

3957121

retrieved

27 July 2017

(Q33459052)

Treatment of persistent or recurrent ovarian carcinoma with sequential methotrexate and 5-fluorouracil

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)